NeOnc gets FDA manufacturing feedback for NEO212 tablet transition

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/14/2026

1. ORCL
2. NVDA
3. SPY
4. DFTX
5. AZN
6. SATL
7. SRRK
8. LYNX
9. BBNX
10. USO

Go back to NeOnc gets FDA manufacturing feedback for NEO212 tablet transition
(NASDAQ: NTHI) Delayed: 3.83 +0.15 (4.08%)
Previous Close $3.68    52 Week High $ 
Open $3.82    52 Week Low $ 
Day High $3.88    P/E N/A 
Day Low $3.74    EPS $ 
Volume 24,805